June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
B vitamins and incidence of advanced AMD: the Alienor Study
Author Affiliations & Notes
  • Benedicte MJ Merle
    Bordeaux Population Health, Bordeaux, Nouvelle-Aquitaine, France
  • Stéphanie BARTHES
    Bordeaux Population Health, Bordeaux, Nouvelle-Aquitaine, France
  • Audrey Cougnard-Gregoire
    Bordeaux Population Health, Bordeaux, Nouvelle-Aquitaine, France
  • Catherine FEART
    Bordeaux Population Health, Bordeaux, Nouvelle-Aquitaine, France
  • Marie-Noelle DELYFER
    Centre Hospitalier Universitaire de Bordeaux, Bordeaux, Aquitaine, France
    Bordeaux Population Health, Bordeaux, Nouvelle-Aquitaine, France
  • Jean-Francois Korobelnik
    Centre Hospitalier Universitaire de Bordeaux, Bordeaux, Aquitaine, France
    Bordeaux Population Health, Bordeaux, Nouvelle-Aquitaine, France
  • Cecile Delcourt
    Bordeaux Population Health, Bordeaux, Nouvelle-Aquitaine, France
  • Footnotes
    Commercial Relationships   Benedicte Merle Thea Pharma, Code R (Recipient); Stéphanie BARTHES None; Audrey Cougnard-Gregoire laboratoires Théa, Code R (Recipient); Catherine FEART laboratoire Lescuyer, Synadiet, Code C (Consultant/Contractor), nutricia Research, Code R (Recipient); Marie-Noelle DELYFER Allergan, Horus Pharma, Bayer, Laboratoires Théa, Novartis, Code C (Consultant/Contractor); Jean-Francois Korobelnik Allergan-Abbvie, Bayer, Janssen, Kanghong, NanoRetina, Novartis, Novonordisk, Roche, Thea, Carl Zeiss Meditec, Code C (Consultant/Contractor); Cecile Delcourt Allergan, Laboratoire Chauvin, Laboratoires Théa, Novartis, Code C (Consultant/Contractor)
  • Footnotes
    Support  Laboratoires Théa, Fondation Voir et Entendre, Agence Nationale de la Recherche (ANR 2010-PRSP-011 VISA), French Ministry of Health (PHRC 12_157, ECLAIR), CFSR Recherche (Club Français des Specialistes de la Retine), Fondation Visio and CNSA (Caisse Nationale pour la Solidarité et l’Autonomie).
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2533 – A0102. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Benedicte MJ Merle, Stéphanie BARTHES, Audrey Cougnard-Gregoire, Catherine FEART, Marie-Noelle DELYFER, Jean-Francois Korobelnik, Cecile Delcourt; B vitamins and incidence of advanced AMD: the Alienor Study. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2533 – A0102.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Nutritional status is linked to onset and progression of advanced forms of age-related macular degeneration (AMD). Among various nutrients, higher dietary and plasma status of B vitamins has been associated with reduced AMD risk in several studies, but prospective studies are scarce. We report the associations of dietary intake and plasma status of B vitamins with the incidence of advanced AMD in French elderly subjects.

Methods : The Alienor study is an ongoing population-based cohort of 963 elderly residents of Bordeaux followed every 2-year since 2006. AMD was classified on the basis of color fundus photographs and spectral domain optical coherence tomography examinations (2006-17), and with self-reported AMD (2001-06). Dietary intakes of vitamins B1, B2, B3, B5, B6, B9 and B12 and total energy intake (TEI) were estimated from a 24-hour dietary recall performed at home by trained dieticians (2001). Plasma status of vitamins B6, B9 and B12 were measured from fasting blood sample (1999). Cox models were used to assess associations between B vitamins and AMD. Models were adjusted for age, sex, smoking status, HDL-cholesterol, genetic risk score, oral supplementation for AMD, BMI and physical activity, with additional adjustment for TEI for dietary B vitamins.

Results : Among 861 participants at risk for advanced AMD with available data for B vitamins, 93 (10.8%) developed advanced AMD. At any time after inclusion, the hazard of advanced AMD onset was significantly 28% lower when the intake of vitamin B5 was 1-SD (1.84mg) higher at inclusion (HR=0.72; 95%CI: 0.53-0.99). The hazard of advanced AMD onset was significantly 10% lower when intake of vitamin B6 was 1-SD (0.60mg) higher at inclusion (HR=0.90; 95%CI: 0.81-0.99). No statistically significant associations were found with intakes of other B vitamins.
At any time after inclusion, participants with a normal status for vitamin B9 (≥10 nmol/L) at inclusion had a 2-fold lower hazard of advanced AMD onset compared with participants with a deficient status for vitamin B9 (HR=0.49, 95%CI: 0.25-0.95). Plasma vitamins B6 and B12 were not significantly associated with AMD.

Conclusions : Higher dietary intake of vitamin B5, B6 and plasma vitamin B9 were associated with a lower risk of AMD. Sufficient intakes of B vitamins, mainly B5 (animal products, whole grains) and B6 (whole grains, liver), as well as a normal status of plasma vitamin B9, may help to prevent development of advanced AMD.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×